TGFB1 and neoplasm: Tumour cell-derived TGFβ1 increased the generation of myofibroblastic cells, which promote the invasion of tumour cells in an in-vitro 3D model [15] and which can be prevented by redox-active nanoparticles (stromal therapy) [16].